AU2002353251A1 - Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds - Google Patents

Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds

Info

Publication number
AU2002353251A1
AU2002353251A1 AU2002353251A AU2002353251A AU2002353251A1 AU 2002353251 A1 AU2002353251 A1 AU 2002353251A1 AU 2002353251 A AU2002353251 A AU 2002353251A AU 2002353251 A AU2002353251 A AU 2002353251A AU 2002353251 A1 AU2002353251 A1 AU 2002353251A1
Authority
AU
Australia
Prior art keywords
antithrombic
polymorphs
compounds
clopidogrel hydrochloride
clopidogrel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002353251A
Other languages
English (en)
Inventor
Jozsef Barkoczy
Bela Farkas
Tamas Gregor
Gyulane Kortvelyessy
Peter Kotay Nagy
Kalman Nagy
Gyula Simig
Zsuzsa Szent Kirallyi
Gyorgyi Vereczkeyne Donath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2002353251A1 publication Critical patent/AU2002353251A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
AU2002353251A 2002-02-06 2002-12-20 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds Abandoned AU2002353251A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0200438A HUP0200438A3 (en) 2002-02-06 2002-02-06 Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0200438 2002-02-06
PCT/HU2002/000157 WO2003066637A1 (en) 2002-02-06 2002-12-20 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds

Publications (1)

Publication Number Publication Date
AU2002353251A1 true AU2002353251A1 (en) 2003-09-02

Family

ID=89980128

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002353251A Abandoned AU2002353251A1 (en) 2002-02-06 2002-12-20 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds

Country Status (15)

Country Link
US (1) US20050113406A1 (WO2006108709A1)
EP (1) EP1474427A1 (WO2006108709A1)
JP (1) JP2005522441A (WO2006108709A1)
KR (1) KR20040079987A (WO2006108709A1)
AU (1) AU2002353251A1 (WO2006108709A1)
BG (1) BG108868A (WO2006108709A1)
CZ (1) CZ2004901A3 (WO2006108709A1)
EA (1) EA007119B1 (WO2006108709A1)
HR (1) HRP20040741A2 (WO2006108709A1)
HU (1) HUP0200438A3 (WO2006108709A1)
IS (1) IS7385A (WO2006108709A1)
PL (1) PL370038A1 (WO2006108709A1)
SK (1) SK3362004A3 (WO2006108709A1)
WO (1) WO2003066637A1 (WO2006108709A1)
YU (1) YU69604A (WO2006108709A1)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1713812A1 (en) * 2004-01-13 2006-10-25 Zentiva, a.s. New crystalline forms of clopidogrel hydrobromide and methods of their preparation
WO2005104663A2 (en) * 2004-03-05 2005-11-10 Ipca Laboratories Limited Industrial process for preparation of clopidogrel hydrogen sulphate
RU2328501C1 (ru) * 2004-04-09 2008-07-10 Ханми Фарм. Ко., ЛТД Кристаллический клопидогрель нафталинсульфонат или его гидрат, способ его получения и содержащая его фармацевтическая композиция
CN1997647A (zh) * 2004-04-20 2007-07-11 赛诺菲-安万特 氯吡格雷盐及其多晶型物
CA2562507A1 (en) * 2004-04-20 2005-11-03 Sanofi-Aventis Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
WO2005117866A1 (en) * 2004-06-01 2005-12-15 Ivax Pharmaceuticals S.R.O. Amorphous clopidogrel hydrochloride and its antithrombotic use
EP1674468A1 (en) * 2004-12-21 2006-06-28 Ratiopharm GmbH Polymorphs of clopidogrel hydrobromide
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
WO2007029096A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Novel polymorphic forms of clopidogrel hydrochloride
WO2007029080A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Preparation of form i of clopidogrel hydrochloride
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR100742134B1 (ko) * 2006-02-07 2007-07-24 경동제약 주식회사 결정성Ｓ-(+)-메틸-2-(2-클로로페닐)-2-(6,7-디히드로티에노[3,2-ｃ]피리딘-5(4Ｈ)-일)아세테이트·캄실레이트를 포함하는약학적 조성물
WO2008004249A2 (en) * 2006-07-04 2008-01-10 Msn Laboratories Limited An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
US8343995B2 (en) 2007-04-27 2013-01-01 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US7985859B2 (en) * 2007-05-30 2011-07-26 Wockhardt Ltd. Processes for the preparation of clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
KR20190071006A (ko) 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
CN102120745B (zh) * 2011-01-31 2013-04-10 天津红日药业股份有限公司 一种盐酸氯吡格雷的晶型ⅰ及其制备方法和用途
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN102367257B (zh) * 2011-11-21 2014-05-07 天津红日药业股份有限公司 氯吡格雷盐酸盐的单晶晶型，它们的制备及应用
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5189170A (en) * 1989-09-29 1993-02-23 Sanofi Process for the preparation of phenylacetic derivatives of thieno-pyridines
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
HU225504B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides

Also Published As

Publication number Publication date
KR20040079987A (ko) 2004-09-16
EP1474427A1 (en) 2004-11-10
HU0200438D0 (en) 2002-04-29
IS7385A (is) 2004-08-05
EA200401025A1 (ru) 2004-12-30
WO2003066637A1 (en) 2003-08-14
US20050113406A1 (en) 2005-05-26
CZ2004901A3 (cs) 2005-02-16
JP2005522441A (ja) 2005-07-28
HRP20040741A2 (en) 2004-12-31
HUP0200438A3 (en) 2003-10-28
HUP0200438A2 (hu) 2003-09-29
YU69604A (sh) 2006-08-17
BG108868A (en) 2005-09-30
EA007119B1 (ru) 2006-06-30
PL370038A1 (en) 2005-05-16
SK3362004A3 (sk) 2005-03-04

Similar Documents

Publication Publication Date Title
AU2002353251A1 (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
PL376575A1 (pl) Podstawione związki heterocykliczne oraz sposoby wykorzystania
GB0325192D0 (en) Method of use
AU2003251247A1 (en) Methods for preparation of olanzapine polymorphic form i
GB0305150D0 (en) Use of therapeutic compounds
ZA200407609B (en) Use of vitamin d compounds
EP1678157A4 (en) Heterocyclic compounds and process for their preparation and use
EP1562900A4 (en) POLYMORPH OF BICIFADINHYDROCHLORIDE
IL175654A0 (en) Cycloalkyl derivatives of 3-hydroxy -4-pyridinones
AU2003250858A1 (en) Use of organic compounds
AU2003295638A8 (en) Novel inhibitors of beta-lactamase
EP1545287A4 (en) VASOREGULATORY COMPOUNDS AND METHODS RELATING TO THEIR USE
AU2003276011A1 (en) Use of molded bodies for external application
AU2003262141A1 (en) Preperation of desloratatine
GB0304555D0 (en) Compounds and methods of manufacture
PL1656358T3 (pl) Trwały polimorf mesylanu bifeprunoksu
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003225049A1 (en) Polymorph of ascomycin derivative
AU2003238034A1 (en) Novel use of imidazotriazinones
AU2003274043A1 (en) Novel use of dioxocin-5-on derivatives
AU2003242773A1 (en) Use of organic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase